U.S. Diabetes Glucose Self-Monitoring Devices Markets Test Strip Margins and Revenues Decide Profitability in 'Free Meter' Market “The growth in self-monitoring has fuelled the emergence of new technologies. The new non-invasive or minimally invasive options on the horizon could revolutionize blood glucose self-monitoring in the years ahead. Perhaps the greatest challenge for manufacturers will be for new technologies to move from being adjunctive to the finger stick method to being a viable stand-alone alternative. Also, far more important than time to market, favorable pricing options hold the promise of high adoption rates.” Medical Monitoring Analyst Team Frost & Sullivan

The incidence of Diabetes is on the rise. Given an aging population, poor health habits and sedentary lifestyles, Type 2 Diabetes is growing at an unprecedented rate. There is increased awareness of glucose self-monitoring among diagnosed diabetics. There have been a host of product improvements and innovations within the glucose monitoring industry. This has also boosted glucose self-monitoring. The recent economic slow down has negatively impacted the healthcare industry. Insurance companies, burdened by cost containment pressures, are passing along costs to consumers in the form of higher co-pays and imposing pricing limits on manufacturers of glucose self-monitoring devices. The emergence of minimally- and non-invasive technologies appears to be a beginning for more new product introductions in this area. Industry Trends

Industry trends analysis and indepth discussion of business strategies Market revenues and forecasts from 1999 to 2009 by: Glucose self-monitoring meters market Glucose self-monitoring test strips market Utilization analysis from 1999 to 2009 by: Market segment Pricing analysis by market segment Market shares of the leading glucose self-monitoring device manufacturers Market drivers and restraints for each market segment Industry challenges and strategies Key Features

Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning growth strategies to help readers create a competitive edge What We Offer

Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities Technology Providers Understand the technology adoption within the Glucose self- monitoring market Position yourself to capitalize on the market’s unmet needs Investment Community Determine which participants will outperform the competition Assess attractiveness of investing in the Continuous, Minimally- and Non-Invasive technologies Who Will Benefit?

 Revenue Streams by Market Segment: Glucose self- monitoring meters and test strips  Market Share and Product Profiles of Market Leaders  Pricing and Utilization Analysis by Segment  New Technologies and a Special Focus on Minimally- Invasive Techniques and Players What’s Included

Abbott Laboratories Bayer Diagnostics/ Bayer AG Becton, Dickinson and Company Cell Robotics International, Inc. Cygnus, Inc. Home Diagnostics, Inc. LifeScan, Inc. Medisys Plc Polymer Technology Systems, Inc. QuestStar Medical, Inc. Roche Diagnostics Corp. TheraSense, Inc. Key Market Participants

Call toll free 877 G O F ROST ( ) Fax toll free Visit For More Information